Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.75 USD | -0.28% | 0.00% | +209.73% |
May. 09 | Earnings Flash (NKTR) NEKTAR THERAPEUTICS Reports Q1 Revenue $21.6M, vs. Street Est of $15.3M | MT |
May. 09 | Transcript : Nektar Therapeutics, Q1 2024 Earnings Call, May 09, 2024 |
Financials (USD)
Sales 2024 * | 76.08M | Sales 2025 * | 68.35M | Capitalization | 321M |
---|---|---|---|---|---|
Net income 2024 * | -155M | Net income 2025 * | -170M | EV / Sales 2024 * | 2.72 x |
Net cash position 2024 * | 115M | Net cash position 2025 * | 281M | EV / Sales 2025 * | 0.58 x |
P/E ratio 2024 * |
-2.17
x | P/E ratio 2025 * |
-2.47
x | Employees | 137 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.63% |
Latest transcript on Nektar Therapeutics
1 day | -0.28% | ||
Current month | +19.86% | ||
1 month | +41.13% | ||
3 months | +163.71% | ||
6 months | +236.54% | ||
Current year | +209.73% |
Managers | Title | Age | Since |
---|---|---|---|
Howard Robin
CEO | Chief Executive Officer | 71 | 06-12-31 |
Robert Chess
CHM | Chairman | 66 | 91-11-30 |
Sandra Gardiner
DFI | Director of Finance/CFO | 58 | 23-04-16 |
Members of the board | Title | Age | Since |
---|---|---|---|
R. Greer
BRD | Director/Board Member | 65 | 09-12-31 |
Roy Whitfield
BRD | Director/Board Member | 70 | 00-07-31 |
Robert Chess
CHM | Chairman | 66 | 91-11-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.32% | 14 M€ | -2.98% | ||
0.06% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-20 | 1.75 | -0.28% | 1,560,200 |
24-05-17 | 1.755 | -2.50% | 1,142,530 |
24-05-16 | 1.8 | -1.64% | 1,451,543 |
24-05-15 | 1.83 | +3.39% | 1,349,246 |
24-05-14 | 1.77 | +1.14% | 1,459,470 |
Delayed Quote Nasdaq, May 20, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+209.73% | 322M | |
+34.35% | 693B | |
+29.39% | 584B | |
-3.49% | 372B | |
+20.15% | 332B | |
+6.19% | 294B | |
+14.11% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+9.21% | 168B |
- Stock Market
- Equities
- NKTR Stock